We are hard at work analyzing the data collected from our 2017 Compensation Survey. I’m pleased to report that we reached our goal of 2,500 participants in this survey, making it the largest survey of its kind and the most accurate source for ID physician compensation data. This larger sample size will enable us to make comparisons across focus areas within the field such as pediatrics, research, clinical practice, public health and industry and across geographic differences and age differences. It is our hope that it will also provide us with insight into the pay disparity across gender identified in our 2015 survey.
A recent review of drugs used to treat hepatitis C by the Cochrane Group drew a heated response from IDSA and AASLD who partner in hcvguidelines.org, an online resource providing guidance in the treatment of the virus. The groups submitted a letter to the Cochrane editors outlining their concerns and calling for the revision or withdrawal of the review. The groups also detailed their objections to the review in commentaries published in their respective journals.
Having fallen short of securing the votes needed to pass the Better Care Reconciliation Act, the Senate is expected to vote early the week of July 24 on a bill that will repeal key parts of the Affordable Care Act, including the Medicaid Expansion, premium tax credits, and cost sharing subsidies, without a replacement plan. HIVMA has been active in opposing replace and repeal efforts on several fronts.
The National Institutes of Health has announced that it will abandon the implementation of its controversial Grant Support Index at this time based on feedback from an advisory council, IDSA, and other stakeholders. Instead, the agency will create a special fund, to be called the Next Generation Researchers Initiative, for early- and mid-career investigators to increase support for researchers with less than 10 years’ experience as an NIH-funded principal investigator.